Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mack

Showing results (181-190 of 444) with videos related to

Pageof 45
Sort By:
Seminars in Oncology|March 15, 2002
Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxiaDavid R Gandara, Primo N Lara, Zelanna Goldberg, et al.
American Journal of Epidemiology|January 25, 2003
Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in new MexicoMichael G Landen, Stuart Castle, Kurt B Nolte, et al.
Cancer Chemotherapy and Pharmacology|June 7, 2011
Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapyWilliam S Holland, Clifford G Tepper, Jose E Pietri, et al.
The Annals of Thoracic Surgery|October 11, 2014
Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation: a word of cautionBrian R Englum, Elizabeth N Pavlisko, Molly C Mack, et al.
Journal of the American Chemical Society|January 3, 2019
Mechanistic Study of Ruthenium-Catalyzed C-H Hydroxylation Reveals an Unexpected Pathway for Catalyst ArrestJames B C Mack, Katherine L Walker, Sophia G Robinson, et al.
Brain Pathology (Zurich, Switzerland)|February 26, 2013
Emerging insights into the ependymoma epigenomeStephen C Mack, Hendrik Witt, Xin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
RB status as a determinant of response to UCN-01 in non-small cell lung carcinomaP C Mack, D R Gandara, C Bowen, et al.
Clinical Lung Cancer|June 9, 2012
Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneityDavid R Gandara, Tianhong Li, Primo N Lara, et al.
Clinical Lung Cancer|January 12, 2008
Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separationChristopher M Mahaffey, Angela M Davies, Primo N Lara, et al.
Journal of Exposure Analysis and Environmental Epidemiology|March 12, 2004
Assessment of urinary metals following exposure to a large vegetative fire, New Mexico, 2000Mitchell I Wolfe, Joshua A Mott, Ronald E Voorhees, et al.
Pageof 45

Showing results (181-190 of 444) with videos related to

Sort By:
Pageof 45
Seminars in Oncology|March 15, 2002
Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxiaDavid R Gandara, Primo N Lara, Zelanna Goldberg, et al.
American Journal of Epidemiology|January 25, 2003
Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in new MexicoMichael G Landen, Stuart Castle, Kurt B Nolte, et al.
Cancer Chemotherapy and Pharmacology|June 7, 2011
Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapyWilliam S Holland, Clifford G Tepper, Jose E Pietri, et al.
The Annals of Thoracic Surgery|October 11, 2014
Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation: a word of cautionBrian R Englum, Elizabeth N Pavlisko, Molly C Mack, et al.
Journal of the American Chemical Society|January 3, 2019
Mechanistic Study of Ruthenium-Catalyzed C-H Hydroxylation Reveals an Unexpected Pathway for Catalyst ArrestJames B C Mack, Katherine L Walker, Sophia G Robinson, et al.
Brain Pathology (Zurich, Switzerland)|February 26, 2013
Emerging insights into the ependymoma epigenomeStephen C Mack, Hendrik Witt, Xin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
RB status as a determinant of response to UCN-01 in non-small cell lung carcinomaP C Mack, D R Gandara, C Bowen, et al.
Clinical Lung Cancer|June 9, 2012
Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneityDavid R Gandara, Tianhong Li, Primo N Lara, et al.
Clinical Lung Cancer|January 12, 2008
Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separationChristopher M Mahaffey, Angela M Davies, Primo N Lara, et al.
Journal of Exposure Analysis and Environmental Epidemiology|March 12, 2004
Assessment of urinary metals following exposure to a large vegetative fire, New Mexico, 2000Mitchell I Wolfe, Joshua A Mott, Ronald E Voorhees, et al.
Pageof 45